This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / High Tide Q2 2026 Earnings
Business earnings announcement

High Tide Q2 2026 Earnings

Analysis based on 6 articles · First reported Jun 03, 2026 · Last updated Jun 03, 2026

Sentiment
0
Attention
3
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The announcement of High Tide Inc.'s second fiscal quarter 2026 financial results will provide investors with key insights into the company's performance, potentially influencing its stock price. The grant of employee stock options could be viewed positively as an incentive for employee retention and alignment with shareholder interests.

Cannabis Retail Pharmaceutical
Event Summary

High Tide Inc. announced it will release its financial and operational results for the second fiscal quarter ended April 30, 2026, after financial markets close on Monday, June 15, 2026. Following this, Raj Grover, Founder and CEO, and Mayank Mahajan, CFO, will host a webcast on Tuesday, June 16, 2026, to discuss the results and future outlook. Additionally, High Tide Inc. granted 66,500 incentive stock options to various employees, exercisable at the closing price of its common shares on the TSX Venture Exchange, with a three-year expiry and two-year vesting period. The company highlighted its subsidiaries Canna Cabana and Remexian Pharma GmbH, and its operations in Canada and Germany.

Entities Involved
stock
High Tide Inc.
High Tide Inc. announced it will release its second fiscal quarter 2026 financial and operational results and granted 66,500 incentive stock options to employees. This event provides transparency into the company's performance and employee incentives.
Importance 100.0 Sentiment 0.0
per
Raj Grover
Raj Grover, Founder and Chief Executive Officer of High Tide Inc., will host a webcast to discuss the company's financial results and future outlook.
Importance 60.0 Sentiment 0.0
per
Mayank Mahajan
Mayank Mahajan, Chief Financial Officer of High Tide Inc., will co-host the webcast to discuss the company's financial results.
Importance 60.0 Sentiment 0.0
stock
Canna Cabana
Canna Cabana is a wholly owned subsidiary of High Tide Inc. and is highlighted as the largest cannabis retail chain in Canada, contributing to High Tide Inc.'s overall business profile.
Importance 40.0 Sentiment 0.0
priv
Remexian Pharma GmbH
Remexian Pharma GmbH is a leading German pharmaceutical company and a part of High Tide Inc.'s operations, focusing on medical cannabis distribution in Germany.
Importance 40.0 Sentiment 0.0
cnt
Canada
Canada is the primary market for High Tide Inc.'s retail operations through Canna Cabana, and it is also one of the countries from which Remexian Pharma GmbH is licensed to import medical cannabis.
Importance 30.0 Sentiment 0.0
cnt
Germany
Germany is a key market for High Tide Inc., where it launched a bricks-and-mortar presence in 2025 and where its subsidiary Remexian Pharma GmbH operates in the medical cannabis market.
Importance 30.0 Sentiment 0.0
exch
TSX Venture Exchange
The TSX Venture Exchange is where High Tide Inc.'s common shares are listed, and the exercise price for the granted stock options is based on its closing price.
Importance 20.0 Sentiment 0.0
Relationships
Canada related ↔ Germany
Canada related ↔ TSX Venture Exchange
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.